Clinical Trials on Anti-PD-1 Antibody
Total 283 results
-
University Hospital, MontpellierCompletedPatients Recieving Anti-PD-1 or Anti-PD-L1 ImmunotherapiesFrance
-
Ningbo Cancer HospitalUnknownAdvanced Malignancies | PD-1 Antibody | CAR-T CellsChina
-
Shanghai International Medical CenterUnknownAdvanced Solid Tumor | PD-1 Antibody | CAR-T CellsChina
-
Beijing Friendship HospitalNot yet recruiting
-
Chinese PLA General HospitalRecruitingHodgkin Lymphoma | Anti-PD-1 Antibody ResistantChina
-
Peking Union Medical College HospitalRecruitingAnlotinib | Anti-PD-1 Antibody | Advanced Pancreatic CancerChina
-
West China HospitalFirst Affiliated Hospital of Chongqing Medical University; Sichuan Cancer Hospital... and other collaboratorsRecruitingRectal Cancer | Radiotherapy | Anti-PD-1 Antibody | MSI-H | Mmr DeficiencyChina
-
Zhejiang Cancer HospitalNot yet recruitingGastric Cancer, HIPEC, Anti-PD-1 Antibody Camrelizumab (SHR-1210), Chemotherapy and SurgeryChina
-
Lei LiCompletedChemotherapy | Recurrent Cervical Carcinoma | Immunotherapy | Anti-PD-1 Antibody | Persistent Advanced Cervical CarcinomaChina
-
Lei LiRecruitingChemotherapy | Recurrent Cervical Carcinoma | Immune Checkpoint Inhibitors | Anti-PD-1 Antibody | Persistent Advanced Cervical Carcinoma | Albumin-bound PaclitaxelChina
-
Sichuan Cancer Hospital and Research InstituteNot yet recruitingIntrahepatic Cholangiocarcinoma | Apatinib | PD-1 Antibody | Transarterial ChemoembolizationChina
-
Anhui Provincial HospitalNot yet recruitingHigh Titers of Anti-HLA Antibody (MFI ≥5000)China
-
China Medical University, ChinaNot yet recruitingPD-1 Antibody | Gastrointestinal Tumours | DC-Cell | NK-Cell
-
Assistance Publique - Hôpitaux de ParisEtablissement Français du Sang (Nouvelle Aquitaine)Recruiting
-
Shanghai Zhongshan HospitalActive, not recruitingBiliary Tract Cancer | PD-1 Antibody | Lenvatinib | GemoxChina
-
Nanjing University School of MedicineCompletedVasculitis | Anti-Neutrophil Cytoplasmic AntibodyChina
-
Beijing Friendship HospitalCompletedCamrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer.Biliary Tract Cancer | Capecitabine | Targeted Molecular Therapy | Anti-PD-1 TherapyChina
-
Guohui LiRecruitingPD-1 | Immune Related Adverse EventsChina
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer | Solid Tumors | Programmed Cell Death-1 (PD1, PD-1) | Programmed Cell Death 1 Ligand 1(PDL1, PD-L1) | Programmed Cell Death 1 Ligand 2 (PDL2, PD-L2)Japan
-
Sun Yat-sen UniversityRecruitingImmunotherapy | DMMR Colorectal Cancer | Anti PD-1China
-
Medical University of GrazTerminatedAnti-SARS-CoV-2 Antibody ResponseAustria
-
Shanghai Jiao Tong University School of MedicineRecruitingOral Squamous Cell Carcinoma | Anti-PD-1 | Neoadjvant Therapy | Anti-VEGFRChina
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Platinum-resistant Ovarian Cancer | Locally Advanced Solid Tumor | Post Anti-PD-1 Melanoma | 2L+ Cervical Cancer | Neoadjuvant Melanoma | Neoadjuvant Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Small Cell...United States, Australia, Korea, Republic of
-
AmgenCompletedAnti-neutrophil Cytoplasmic Antibody-associated VasculitisUnited States
-
AmgenCompletedAnti-neutrophil Cytoplasmic Antibody-associated VasculitisJapan
-
The Second Affiliated Hospital of Chongqing Medical...Guizhou Provincial People's Hospital; The Affiliated Hospital Of Southwest...Not yet recruitingChronic Hepatitis b | Anti-PD-1 Antibody | Peg-IFNαChina
-
The Second Affiliated Hospital of Chongqing Medical...Guizhou Provincial People's Hospital; The Affiliated Hospital Of Southwest...Not yet recruitingChronic Hepatitis b | Anti-PD-1 AntibodyChina
-
AmgenCompletedAnti-neutrophil Cytoplasmic Antibody-associated VasculitisUnited States
-
Xuanwu Hospital, BeijingUnknownNon-small Cell Lung Cancer | PD-1 Antibody | Lung Cancer Stage II
-
Peking UniversityNot yet recruitingGastroesophageal Junction Cancer | Chemoradiotherapy | PD-1
-
The First Hospital of Jilin UniversityNot yet recruitingLocally Advanced Rectal Cancer | Anti-PD-1 | Total Neoadjuvant TreatmentChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingChemotherapy Effect | Lung Cancer Stage IV | PD-1 Antibody | Lung Cancer Squamous CellChina
-
Agenus Inc.CompletedAdvanced Solid Cancers | Advanced Solid Cancers Refractory to PD-1United States
-
Sun Yat-sen UniversityRecruitingPD-1 Inhibitor | G-CSFChina
-
Lei LiUnknownCamrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine CarcinomasChemotherapy | Recurrent Cervical Carcinoma | Adverse Drug Event | Cervical Neuroendocrine Carcinoma | Objective Response Rate | Advanced Cervical Carcinoma | Anti-pd-1 AntibodyChina
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinNot yet recruitingGranulomatosis With Polyangiitis | Anti-neutrophil Cytoplasmic Antibody-associated VasculitisFrance
-
Shanghai Jiao Tong University School of MedicineRecruitingChemotherapy | Oral Squamous Cell Carcinoma | Anti-PD-1 | Neoadjvant TherapyChina
-
West China HospitalRecruitingBRAF V600E-mutated /MSS Metastatic Colorectal Cancer | Vemurafenib (BRAFi) Plus Cetuximab (EGFRi) Combined With PD-1 Monoclonal AntibodyChina
-
National Institute of Allergy and Infectious Diseases...CompletedHIV-1 Infection | HIV Antibodies | Neutralizing Antibody | Viral Load | Monoclonal AntibodyUnited States
-
AmgenCompletedAnti-neutrophil Cytoplasmic Antibody-associated VasculitisUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Shanghai Chest HospitalUnknownChemotherapy Effect | KRAS Gene Mutation | NSCLC Stage IV | PD-1 Antibody
-
Tibotec Pharmaceuticals, IrelandCompleted
-
Mårten SegelmarkHansa Biopharma ABCompletedAnti-Glomerular Basement Membrane Antibody DiseaseAustria, Czechia, Denmark, France, Sweden
-
Sun Yat-sen UniversityCompletedBrain Metastases | NSCLC Stage IV | PD-1 AntibodyChina
-
Staidson (Beijing) Biopharmaceuticals Co., LtdCompletedAntineutrophil Cytoplasmic Antibody Associated VasculitisUnited States
-
AmgenRecruitingAntineutrophil Cytoplasmic Antibody-associated VasculitisUnited States
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsWithdrawnAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisUnited States
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)WithdrawnAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisUnited States
-
Shandong New Time Pharmaceutical Co., LTDNot yet recruiting